The combination of COVID-19 vaccination with immunotherapy by checkpoint inhibitors in cancer patients could intensify immunological stimulation with potential reciprocal benefits. Here, we examine more closely the possible adverse events that can arise in each treatment modality. Our conclusion is that caution should be exercised when combining both treatments.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603902 | PMC |
| http://dx.doi.org/10.1038/s41416-021-01618-0 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 vaccination
8
vaccination cancer
4
cancer immunotherapy
4
immunotherapy stick
4
stick together?
4
together? combination
4
combination covid-19
4
vaccination immunotherapy
4
immunotherapy checkpoint
4
checkpoint inhibitors
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!